| Members |
targetComponentId |
| Mononeuritis of upper limb and mononeuritis multiplex |
Mononeuropathy of upper limb (disorder) |
| Mononeuritis of upper limb and mononeuritis multiplex |
Mononeuritis multiplex |
| Mononucleosis syndrome |
Infectious mononucleosis caused by human herpesvirus 6 |
| Mononucleosis syndrome |
Epstein-Barr virus infectious mononucleosis |
| Mononucleosis syndrome |
Infectious mononucleosis |
| Mononucleosis syndrome |
Infectious mononucleosis caused by human immunodeficiency virus type I |
| Mononucleosis syndrome |
Cytomegaloviral mononucleosis |
| Mononucleosis syndrome |
Infectious mononucleosis caused by human immunodeficiency virus (disorder) |
| Mononucleosis syndrome |
Infectious mononucleosis caused by Adenovirus |
| Mononucleosis syndrome |
Infectious mononucleosis caused by Toxoplasma (disorder) |
| Monotremata species |
Order Monotremata (organism) |
| Monster |
Congenital malformation |
| Mood anorexia |
Loss of appetite |
| Mood anorexia |
No interest in food (finding) |
| Mood anorexia |
Psychogenic loss of appetite |
| Mood disorder with depressive symptoms caused by ecstasy type drug |
Mood disorder with depressive symptoms caused by amfetamine and/or amfetamine derivative (disorder) |
| Mood disorder with manic symptoms caused by ecstasy type drug |
Mood disorder with manic symptoms caused by amfetamine and/or amfetamine derivative (disorder) |
| Mood disorder with mixed depressive and manic symptoms caused by ecstasy type drug |
Mood disorder with mixed depressive and manic symptoms caused by amfetamine and/or amfetamine derivative (disorder) |
| Mood hypersomnia |
Hypersomnia |
| Mood hypersomnia |
Disturbance in mood |
| Mood insomnia |
Disturbance in mood |
| Mood insomnia |
Insomnia |
| Mood, function |
Mood |
| Mood, function |
Emotion function (observable entity) |
| Moorella species |
Moorella |
| Moorfields reading book test |
Child development test |
| Moraxella species |
Moraxella |
| More than 0.05 |
Liver tumor size index more than 0.05 (tumor staging) |
| More than 80% of predicted peak flow rate (& expiratory) |
More than 80 percent of predicted peak expiratory flow rate (finding) |
| Morganella morganii |
Morganella morganii |
| Morganella morganii |
Morganella morganii subsp morganii |
| Morganella species |
Morganella |
| Morning after pill |
Uses morning after pill method of contraception (finding) |
| Morning sickness (& [mild hyperemesis gravidarum]) |
Morning sickness |
| Morning sickness (& [mild hyperemesis gravidarum]) |
Mild hyperemesis gravidarum |
| Morococcus species |
Morococcus |
| Morphine measurement screening |
Measurement of morphine |
| Morphine sulfate + dextrose |
Product containing morphine (medicinal product) |
| Morphine sulfate 100mg m/r capsule |
Product containing precisely morphine sulfate 100 milligram/1 each prolonged-release oral capsule (clinical drug) |
| Morphine sulfate 100mg m/r tablet |
Morphine sulfate 100 mg prolonged-release oral tablet |
| Morphine sulfate 100mg tablet |
Product containing precisely morphine sulfate 100 milligram/1 each prolonged-release oral capsule (clinical drug) |
| Morphine sulfate 100mg tablet |
Morphine sulfate 100 mg prolonged-release oral tablet |
| Morphine sulfate 10mg m/r capsule |
Morphine sulfate 10 mg prolonged-release oral capsule |
| Morphine sulfate 10mg m/r tablet |
Product containing precisely morphine sulfate 10 milligram/1 each prolonged-release oral tablet (clinical drug) |
| Morphine sulfate 10mg/1mL injection |
Morphine sulfate 10 mg/mL solution for injection |
| Morphine sulfate 120mg m/r capsule |
Product containing precisely morphine sulfate 120 milligram/1 each prolonged-release oral capsule (clinical drug) |
| Morphine sulfate 150mg m/r capsule |
Product containing precisely morphine sulfate 150 milligram/1 each prolonged-release oral capsule (clinical drug) |
| Morphine sulfate 15mg m/r tablet |
Product containing precisely morphine sulfate 15 milligram/1 each prolonged-release oral tablet (clinical drug) |
| Morphine sulfate 15mg/1mL injection |
Morphine sulfate 15 mg/mL solution for injection |
| Morphine sulfate 200mg m/r capsule |
Morphine sulfate 200 mg prolonged-release oral capsule |
| Morphine sulfate 200mg m/r tablet |
Product containing precisely morphine sulfate 200 milligram/1 each prolonged-release oral tablet (clinical drug) |
| Morphine sulfate 20mg m/r capsule |
Product containing precisely morphine sulfate 20 milligram/1 each prolonged-release oral capsule (clinical drug) |
| Morphine sulfate 20mg/1mL injection |
Product containing precisely morphine sulfate 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Morphine sulfate 20mg/mL concentrated oral solution |
Morphine sulfate 20 mg/mL oral solution |
| Morphine sulfate 20mg/mL solution |
Morphine sulfate 20 mg/mL oral solution |
| Morphine sulfate 30mg m/r capsule |
Morphine sulfate 30 mg prolonged-release oral capsule |
| Morphine sulfate 30mg m/r tablet |
Morphine sulfate 30 mg prolonged-release oral tablet |
| Morphine sulfate 30mg/1mL injection |
Morphine sulfate 30 mg/mL solution for injection |
| Morphine sulfate 50mg m/r capsule |
Product containing precisely morphine sulfate 50 milligram/1 each prolonged-release oral capsule (clinical drug) |
| Morphine sulfate 5mg |
Morphine sulfate 5 mg prolonged-release oral tablet |
| Morphine sulfate 5mg m/r tablet |
Morphine sulfate 5 mg prolonged-release oral tablet |
| Morphine sulfate 60mg m/r capsule |
Product containing precisely morphine sulfate 60 milligram/1 each prolonged-release oral capsule (clinical drug) |
| Morphine sulfate 60mg m/r tablet |
Morphine sulfate 60 mg prolonged-release oral tablet |
| Morphine sulfate 60mg/2mL injection |
Morphine sulfate 30 mg/mL solution for injection |
| Morphine sulfate 90mg m/r capsule |
Product containing precisely morphine sulfate 90 milligram/1 each prolonged-release oral capsule (clinical drug) |
| Mortality prediction model |
Mortality Prediction Model II (assessment scale) |
| Mortality prediction model score |
Mortality Prediction Model II score (observable entity) |
| Morus alba pollen allergen |
Morus alba pollen |
| Mosaicism 45, X / other cell line with abnormal sex chromosome |
Mosaicism 45, X or other cell line with abnormal sex chromosome |
| Mosquito |
Family Culicidae (organism) |
| Mossy foot disease |
Lymphedema due to podoconiosis (disorder) |
| Mossy foot disease |
Podoconiosis (disorder) |
| Mossy-throated bellbird |
Procnias albus (organism) |
| Mossy-throated bellbird |
Procnias averano (organism) |
| Motility |
Motile microorganism |
| Motivation technique |
Movement therapy |
| Motivation technique |
Speech therapy |
| Motivation technique |
Occupational therapy |
| Motor &/or sensory systems examination |
Sensory and motor testing |
| Motor aphasia |
Broca's dysphasia |
| Motor aphasia |
Expressive dysphasia |
| Motor aphasia |
Motor aphasia |
| Motor epilepsy |
Epilepsy |
| Motor neurone disease |
Motor neuron disease |
| Motor neurone disease |
Amyotrophic lateral sclerosis |
| Motor retardation |
Behavior showing reduced motor activity |
| Motor retardation |
Bradykinesia (finding) |
| Motor retardation |
Motor retardation (finding) |
| Motor symptoms (& [paralysis] or [weakness]) |
Muscle weakness |
| Motor symptoms (& [paralysis] or [weakness]) |
Movement disorder |
| Motor symptoms (& [paralysis] or [weakness]) |
Motor nervous system finding |
| Motor symptoms (& [paralysis] or [weakness]) |
Finding of movement (finding) |
| Motor symptoms (& [paralysis] or [weakness]) |
Movement disorder |
| Motor symptoms (& [paralysis] or [weakness]) |
Paralysis |
| Motor symptoms (& [paralysis] or [weakness]) |
Finding of movement (finding) |
| Motor symptoms (& [paralysis] or [weakness]) |
Paralysis |
| Motor symptoms (& [paralysis] or [weakness]) |
Muscle weakness |
| Motor symptoms (& [paralysis] or [weakness]) |
Motor nervous system finding |
| Motor vehicle nontraffic accident involving accidental poisoning from carbon monoxide generated by motor vehicle, except off-road motor vehicle, while in motion, not on public highway |
Accidental poisoning by motor vehicle exhaust gas |
| Motor vehicle nontraffic accident involving collision, not on public highway, between motor vehicle, except off-road motor vehicle, and animal, driver of motor vehicle injured |
Motor vehicle accident off public road |
| Motor vehicle nontraffic accident involving collision, not on public highway, between motor vehicle, except off-road motor vehicle, and animal, motor cyclist injured |
Motor vehicle accident off public road |
FHIR